For ER-/HER2+ disease, our data indicated lower odds of pCR for patients with obesity compared with patients with normal weight, but the estimate was imprecise (ORadj=0.79 [95%CI = 0.35–1.75]). The gene discussed is ERBB2; the disease is obesity due to melanocortin 4 receptor deficiency.